The Board of China SCE Group Holdings Limited announced that Mr. Lu Hong Te (Mr. Lu) has tendered his resignation as an independent non-executive Director with effect from the conclusion of the Annual General Meeting as he wishes to devote more time to his other business commitments. Upon his resignation as an independent non-executive Director becoming effective, Mr. Lu shall resign as a member of each of the audit committee, the nomination committee and the corporate governance committee of the Board with effect from the conclusion of the Annual General Meeting. Upon his election as an independent non-executive Director at the Annual General Meeting, Dr. Mao shall act as a member of each of the audit committee, the nomination committee and the corporate governance committee of the Board.

The Board announced that pursuant to resolution 2(d) passed by the Shareholders at the Annual General Meeting, Dr. Mao Zhenhua (``Dr. Mao'') has been elected as an independent non-executive Director. Set forth below is the biographical information of Dr. Mao: Mao Zhenhua (), aged 59, is currently the chairman of China Chengxin Credit Management Co. Ltd. (``China Chengxin''), a professor at the Renmin University of China, the chairman of the Institute of Economic Research of the Renmin University of China, a professor of Wuhan University and Dean of Dong Fureng Economic & Social Development School of Wuhan University.

He has been a professor at the Business School of the University of Hong Kong since 2022. Dr. Mao graduated from Wuhan University with a doctoral degree in Economics. Dr. Mao founded China Chengxin in 1992.

Since then, he has acted as its general manager and chairman, and later on he has further acted as its chief executive officer. He was the major shareholder and controller of China Cheng Xin International Credit Rating Co. Ltd. Dr. Mao is a non-executive director of Meilleure Health International Industry Group Limited (2327), a company listed on the Stock Exchange, and an independent non-executive director of two other companies listed on the Stock Exchange, namely China Infrastructure & Logistics Group Ltd. (1719) and China Bohai Bank Co.

Ltd. (9668). Save as disclosed above, Dr. Mao has not at any time during the three years preceding the date of this announcement served nor is currently serving as a director of any other listed company in Hong Kong or overseas.